Nanoparticles loaded with bee venom kill HIV
(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of ...
HIV & AIDS
Mar 08, 2013 |
5 / 5 (29) |
3
|
Researchers find potential novel treatment for influenza
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal ...
Diseases, Conditions, Syndromes
May 01, 2013 |
4.3 / 5 (3) |
0
|
Team develops mathematical model to measure hidden HIV
(Medical Xpress)—Scientists have long believed that measuring the amount of HIV in a person's blood is an indicator of whether the virus is actively reproducing. A University of Delaware-led research team ...
HIV & AIDS
May 08, 2013 |
5 / 5 (3) |
0
|
New antiviral treatment could significantly reduce global burden of hepatitis C
(Medical Xpress)—Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and ...
Diseases, Conditions, Syndromes
May 06, 2013 |
not rated yet |
0
Researchers describe first 'functional HIV cure' in an infant
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected ...
HIV & AIDS
Mar 03, 2013 |
5 / 5 (9) |
1
|
New ways viruses affect human immune response discovered
(Medical Xpress) -- New ways that viruses manipulate the human immune response have been revealed in a research paper just published in Nature involving TCD scientists. Dr Orla Mulhern and Professor Andrew Bowie, School of Bio ...
Immunology
Aug 03, 2012 |
5 / 5 (1) |
0
|
Infection warning system in cells contains targets for antiviral and vaccine strategies
Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C. The targets are within the infection ...
Immunology
Jul 30, 2012 |
not rated yet |
0
|
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
4.5 / 5 (2) |
0
Sustained virological response linked with improved survival for patients with chronic HCV infection
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...
Diseases, Conditions, Syndromes
Dec 25, 2012 |
5 / 5 (1) |
0
|
Better long-term outcomes with low hep C viral load
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, ...
Diseases, Conditions, Syndromes
Mar 25, 2013 |
not rated yet |
0
Improved molecular tools streamline influenza testing and management
Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore ...
Diseases, Conditions, Syndromes
Apr 17, 2013 |
not rated yet |
0
Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Op ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
5 / 5 (1) |
0
Antiviral therapy may cut recurrence of hepatitis B-linked liver cancer
(HealthDay)—People with liver cancer tied to infection with the hepatitis B virus who got antiviral therapy after cancer surgery had a lower risk of tumor recurrence than those who did not get it, according ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Drug helps purge hidden HIV virus, study shows
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
HIV & AIDS
Mar 08, 2012 |
4.8 / 5 (5) |
0
Hep B screening urged before TNF-alpha inhibitor therapy
(HealthDay) -- All patients with psoriasis should be screened for hepatitis B surface antigen and hepatitis B core antibody prior to the initiation of tumor necrosis factor-alpha inhibitor therapy, according ...
Diseases, Conditions, Syndromes
Jul 01, 2012 |
not rated yet |
0
